Journal of Bioresource Management
Volume 9

Issue 4

Article 5

Evaluation of Antibacterial Potential of Artemisinin Extracts of
Artemisia Annua In Vivo and In Vitro
Arsalan Khan
Veterinary Research and Disease Investigation Center, Dera Ismail Khan-29050-Pakistan,
drarsalankhandvm@gmail.com

Akhtar Ali
Veterinary Research and Disease Investigation Center, Dera Ismail Khan-29050-Pakistan

Imtiaz Ali Shah
Veterinary Research and Disease Investigation Center, Dera Ismail Khan-29050-Pakistan

Umm-E- Aimen
Veterinary Research and Disease Investigation Center, Dera Ismail Khan-29050-Pakistan

Waseem Ullah
Veterinary Research and Disease Investigation Center, Dera Ismail Khan-29050-Pakistan

See next page for additional authors

Follow this and additional works at: https://corescholar.libraries.wright.edu/jbm
Part of the Bacteriology Commons

Recommended Citation
Khan, A., Ali, A., Shah, I., Aimen, U., Ullah, W., & Khan, I. (2022). Evaluation of Antibacterial Potential of
Artemisinin Extracts of Artemisia Annua In Vivo and In Vitro, Journal of Bioresource Management, 9 (4).
ISSN: 2309-3854 online
(Received: Oct 5, 2022; Accepted: Dec 7, 2022; Published: Dec 17, 2022)
This Article is brought to you for free and open access by CORE Scholar. It has been accepted for inclusion in
Journal of Bioresource Management by an authorized editor of CORE Scholar. For more information, please contact
library-corescholar@wright.edu.

Evaluation of Antibacterial Potential of Artemisinin Extracts of Artemisia Annua
In Vivo and In Vitro
Cover Page Footnote
The authors are highly thankful to the Government of Khyber Pakhtunkhwa, Pakistan for funding of this
research project.

Authors
Arsalan Khan, Akhtar Ali, Imtiaz Ali Shah, Umm-E- Aimen, Waseem Ullah, and Imtiaz Khan
© Copyrights of all the papers published in Journal of Bioresource Management are with its publisher,
Center for Bioresource Research (CBR) Islamabad, Pakistan. This permits anyone to copy, redistribute,
remix, transmit and adapt the work for non-commercial purposes provided the original work and source is
appropriately cited. Journal of Bioresource Management does not grant you any other rights in relation to
this website or the material on this website. In other words, all other rights are reserved. For the
avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute,
broadcast, rebroadcast or show or play in public this website or the material on this website (in any form
or media) without appropriately and conspicuously citing the original work and source or Journal of
Bioresource Management’s prior written permission.

This article is available in Journal of Bioresource Management: https://corescholar.libraries.wright.edu/jbm/vol9/
iss4/5

Khan et al., (2022). Evaluation of Antibacterial Potential of Artemisinin Extracts.
J Biores Manag., 9(4): 42-52

EVALUATION OF ANTIBACTERIAL POTENTIAL OF ARTEMISININ
EXTRACTS OF ARTEMISIA ANNUA IN VIVO AND IN VITRO
ARSALAN KHAN1*, AKHTAR ALI1, IMTIAZ ALI SHAH1, UMM-E-AIMEN1, WASEEM ULLAH1,
AND IMTIAZ KHAN2
1

Veterinary Research and Disease Investigation Center, Dera Ismail Khan-29050-Pakistan
2
Veterinary Research Center, Tank- 29461-Pakistan
Corresponding Author’s email: drarsalankhandvm@gmail.com

ABSTRACT
To ensure universal health care, the World Health Organization recognized the significance
of complementary and alternative medicines (CAM) and recommended the use of natural
herbs and plants bearing therapeutic potential and fewer adverse effects. Therefore, Artemisia
annua herb was evaluated for its antibacterial potential and therapeutic efficacy against
Staphylococcus aureus, Streptococcus and Escherichia coli both in vitro and in vivo.
Artemisinin was extracted from Artemisia annua by chemical treatment. Subsequently, the
culture sensitivity tests were performed on MHA by disk diffusion method to determine the
antibacterial potential of the Artemisinin extracts against the test bacteria (in vitro phase).
The results of this in vitro trial revealed that the test bacteria Staphylococcus aureus
and Streptococcus were significantly sensitive to Artemisinin extracts and showed a diameter
of 27.7 and 22.3mm of the bacteriostatic zone, respectively, while the Escherichia coli was
moderately sensitive to the Artemisinin extracts with the bacteriostatic zone of 12.9mm.
During the 2nd phase of the study (in vivo trial), 20 rabbits were maintained which were
infected with S. aureus and were successfully treated with varying concentrations of the
Artemisinin extracts @ 1 mg/ml, 2 mg/ml and 5 mg/ml in DMSO and were recovered.
Similarly, rabbits infected with Streptococcus were also successfully treated and recovered.
Thereafter, rabbits infected with E. coli were treated with Artemisinin, and out of 15 rabbits
in three test groups, 03 rabbits died while the others were recovered. Hence, as per findings
of this study, Artemisinin extracts were recommended against Staphylococcus
aureus and Streptococcus infections.
Keywords: Artemisinin, alternative medicines, antibacterial potential, Streptococcus
infections.
INTRODUCTION
The research and re-evaluation of
herbal and traditional plants for their
medicinal and therapeutic potential has
been increasing worldwide because plant
remedies are likely to have fewer adverse
effects than synthetic chemical substances
used for therapeutic purposes (Kim et al.,
2015). World Health Organization
recognizes the role of the CAM
(Complementary & Alternative Medicine)
of demonstrated safety, verified quality,
and effectiveness in ensuring universal
access to healthcare. While in duration

from 2014 to 2023, the traditional
medicine strategy of WHO focused the
harness the potential contribution of CAM
pertaining to healthcare. CAM or
medicines derived from herbs or plants are
the potential CAM therapies for
therapeutic objectives (WHO, 2014). Thus,
natural plants can serve as an important
source of novel antibacterial agents,
worldwide (Tajehmiri et al., 2014).
Artemisia annua is a native herb to
Asia, and is in practice in traditional Asian
medicine for centuries, regarding the
treatment and impediment of pyrexia and
malaria. Various compounds are extracted
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from the test herb Artemisia annua
including aliphatic alkanes, coumarins,
Artemisinin,
flavonoids,
phenolics,
purines, sesqui-terpenoids, steroids, triterpenoids (Bhakuni et al., 2001).
Artemisinin is the essential component of
Artemisia annua L. chemically composed
of C15H22O15 (Empirical formula). It was
discovered by Tu Youyou in 1972 and she
was a Nobel Prize recipient in the field of
Medicine, in 2015. Artemisinin is widely
used as an antibacterial, antimalarial,
antitumor,
antifungal,
antioxidant,
antiviral, antileishmanial and antiinflammatory agent (Efferth, 2007;
Konkimalla et al., 2008; Tu, 1999). It is
also used as an acaricidal agent against
Rhiphicephalus microplus ticks. It also has
effectiveness against Schistosomiasis and
gastrointestinal nematodes, in terms of
reduction in the eggs per gram of feces
(Chagas et al., 2011).
The essential oils extracted from
the Artemisia herb have been extensively
used as folk medicine characterized by
antispasmodic,
antipyretic,
antiinflammatory, and abortifacient properties
(Zarga et al., 1995). These essential oils
also serve as chief ingredients in soap and
detergents, perfumes, cosmetics as well as
in aromatherapy. The aerial parts of the
Artemisia annua plant are also used
extensively in Iranian traditional medicine,
for curing hypoglycemic, hypolipidaemic,
anti-inflammatory and diuretic conditions
(Kulkarni, 2002).
Therefore, this study was designed
to investigate and compare the efficacy of
Artemisinin extracts in vitro, on culture
sensitivity tests with commercially used
antibiotics and in vivo antibacterial effect
of Artemisinin in the rabbit models post
bacterial challenge with S. aureus,
Streptococcus and E. coli. And it was
found from the results that Artemisinin
extracts had significant antibacterial
effects @ 1mg/ml MIC (Minimum
Inhibitory Concentration), both in vitro
and in vivo against the test bacteria
Staphylococcus aureus, and Streptococcus,

while, Escherichia coli was moderately
sensitive to Artemisinin extracts.
MATERIALS AND METHODS
Study Area and Period
The study was carried out at
Veterinary
Research
and
Disease
Investigation Center (VR&DIC), Dera
Ismail Khan, Department of Livestock and
Dairy Development (Research), Khyber
Pakhtunkhwa, Pakistan, during the year
2020-21 and 2021-22.
Plant Material
The fresh plant material of
Artemisia annua was procured from the
local nurseries of District Dera Ismail
Khan. The leaves of the plant specimen
were washed with tap water to remove the
dust and debris. Then the collected plant
materials were dried under the shade at
25°C and then mashed with the help of a
mortar and pestle (Figure 1).

Figure 1: Weighing the dried leaves of Artemesia
annua herb.

Production of Artemisinin
About 100 g of plant material of
Artemisia annua was soaked in 1 Liter of
Chloroform (Merck) as a solvent for a
fortnight and was agitated twice a day and
finally filtered. Then the filtrate was
evaporated to acquire the gummy residue
(Figure 2) using a rotary evaporator and
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the extracts were stored in a sterile glass
bottle at room temperature, at STP (Javid
et al., 2015).
Artemisinin is soluble in organic
solvents but is unstable in the form of an
aqueous solution. Therefore, a fresh
solution of Artemisinin was prepared from
the stock solution on each day required in
the experiment @1mg/ml in dimethyl
sulfoxide (DMSO, Merck).

this amount was mathematically calculated
for the number of plates prepared. The
media was reconstituted, as per
instructions of the manufacturer, e.g. 111g
of MSA was dissolved in 1Liter of
distilled water. The media was stirred for
proper mixing of the media powder in
distilled water and was heated to boiling
for complete dissolution. The beaker was
labeled, covered with aluminum foil, and
autoclaved for sterilization purposes. After
autoclaving, the media was poured into
Petri dishes which were left to cool and
solidify. After solidification, the plates
were packed and placed upside down in
the refrigerator for storage and later use
(Lammert and John, 2007).
The following media were used in this
research study.
i.

Figure 2: The gummy residue of Artemisinin
extracts after evaporation of the chloroform.

In Vitro Evaluation of Artemisinin
The
bacteria
including
Staphylococcus aureus, Escherichia coli
and Streptococcus were cultured in the
laboratory facility of the VR&DIC, Dera
Ismail Khan from various samples of
animal origin including milk, feces,
intestinal contents of the poultry, etc. The
filter paper disks were prepared and
impregnated with Artemisinin dissolved in
organic solvents DMSO and were used to
compare with the 06 commercial antibiotic
disks viz amoxicillin, enrofloxacin,
doxycycline, tetracycline, ciprofloxacin
and oxytetracycline in the culture
sensitivity test.
For the isolation and cultivation
of the bacteria, the following media were
used.
Media Preparation
The media required was calculated
as per need. For example; 25-30ml agar
was required for a single large plate and

Mannitol Salt Agar (MSA)

Mannitol salt agar is the selective
media and is used for the isolation and
identification of S. aureus bacteria. The S.
aureus colonies appeared yellow, having
yellow zones, while, the Staphylococcus
species showed red colonies having red
zones. The agar was prepared by
reconstituting the media powder in
distilled water @111g/Liter.
ii.

MacConkey Agar

MacConkey agar is the selective
media and is used for the isolation
of Gram-negative and enteric bacteria,
Escherichia coli, which was selected for
this study. The E. coli are lactose
fermenter bacteria, decreasing the pH of
the agar. Due to decreased pH, the neutral
red MacConkey agar was absorbed by the
bacteria and produced bright pink to red
colonies on the agar. The E. coli colonies
appeared pink to red, gave a doughnut
appearance, and were encircled with a dark
pink area due to the precipitation of bile
salts. The MacConkey agar was prepared
by dissolving the powder in distilled water
at @50g /L.
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iii.

Nutrient Agar

Nutrient agar is a general-purpose
growth media and was used for the growth
of Streptococcus bacteria, which were
identified by cultural and microscopic
methods. The Streptococcus grew as
yellow-colored colonies on the media and
microscopically the bacteria appeared as
chains (Esha and Anuradha, 2019). The
bacteria can also be grown on the blood
agar. The agar is prepared by dissolving
the powder in distilled water @ 28 g/L
(Figure 3).

overnight incubation at 37 0C, tubes were
examined for identification of the bacterial
colonies or growths, showing the turbidity
and the lowest dilution concentration of
the Artemisinin extracts that prevented the
growth of bacteria in the broth (Figure 4),
which was termed as Minimum Inhibitory
Concentration or MIC (Reller et al., 2009).

Figure 4: Broth dilution test in the MSA broth

v.

Figure 3: The selective agar media used for the
bacterial culture in the in vitro tests

iv.

Broth Dilution Test

It is the earliest microbiological
test, also known as the macro broth or tube
dilution method. This method was adapted
before the disk diffusion technique to
determine the antibiotic potential of the
Artemisinin extract by preparing its
dilutions in the liquid growth media e.g.
MSA. Three dilutions were prepared i.e. 1
mg/ml, 2 mg/ml and 5 mg/ml from the
Artemisinin. Then 05 test tubes A, B, C,
D, and E were prepared having broth in
these tubes and bacterial inoculums from
the cultures were introduced into the 04
test tubes, A, B, C and D, while, broth in
the 5th tube “E” served as negative control.
Then Artemisinin dilutions were added as
1mg/ml, 2mg/ml and 5mg/ml in test tubes
A, B and C, respectively, while, D served
as positive control having inoculums only
and E served as negative control (without
inoculums and Artemisinin extracts). After

Kirby Bauer
Technique

Disk

Diffusion

The bacterial inoculums acquired
from cultures were applied to MHA
(Muller-Hinton Agar) plates of larger
surface area, by streaking method of the
sterile cotton swab. The plates were
allowed to dry for 5 minutes. Then the
Artemisinin impregnated disks along with
the commercial disks were placed on the
inoculated agar, using thumb forceps
(Figure 5).
After 24-48 hours of
incubation of Petri dishes at 37 0C, the
zones of growth inhibition were measured
around each disk up to the nearest
millimeter values. The zone diameters of
these disks were interpreted using the
criteria published by the Clinical and
Laboratory Standards Institute (CLSI). The
qualitative results of the disk diffusion test
were recorded as S (susceptible), I
(intermediate/moderate), or R (resistant)
rather than MIC values (Bauer et al., 1966;
Reller et al., 2009).
vi.

In
Vivo
Artemisinin

Evaluation

Of

For in vivo test, 20 rabbits of the
same age and breed were procured and
divided into five groups viz Group A, B,
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C, D and E. After an acclimatization
period of 02 weeks, the rabbit models of
each group were challenged with the
Staphylococcus aureus and Streptococcus
bacterial infection through intra-dermal
inoculation route. For this purpose, the
bacterial colonies (standard is 300
CFU/colony forming units) were diluted in
0.1ml Phosphate Buffer Saline (PBS)
(Silvestre et al., 2020).

The Escherichia coli were injected
intra-peritoneally into the rabbits @1.0 ml
of E. coli suspension (@108 CFU/ml) and
rabbit models were thus infected (Guo et
al., 2017).
Rabbits of Group E (negative
control) were administered with 1.00 mL
phosphate buffer saline instead of bacteria.
The group allocation of the experimental
rabbits is given in Table 1.
Then the rabbits were treated using
different concentrations of Artemisinin
@1 mg/ml, 2 mg/ml and 5 mg/ml,
respectively, via the intramuscular route,
Group D served as positive control and
was treated using commercial antibiotics
e.g. amoxicillin @5 mg/kg body weight
for 05 days, while, Group E served as
negative control (not infected with
bacteria) and treated using a placebo (1 ml
phosphate buffer saline) through the
intramuscular route (Figure 6).
RESULTS & DISCUSSION
Samples Cultured
To evaluate the antibacterial
potential of the herb Artemisia annua,
Artemisinin was extracted from this herb
and was comparatively studied with the
commercially available antibiotics, in vitro
as well as in vivo.
To isolate the pure cultures of the
bacteria, subcultures were prepared from
all the growths on their respective media
(Figure 7). And then the selected plates
were streaked on the MHA (Merck,
Germany) for a culture sensitivity test and
comparison of the test herb, the
Artemisinin
extracts
with
the
commercially available antibiotics (Figure
8).

Figure 5: Kirby Bauer disk diffusion method
and placing the antibiotic discs on the MHA

Broth Dilution Test
The samples cultured were
subjected to the broth dilution test, for the
determination of the antibiotic potential of
the Artemisinin extracts by preparing its
dilutions in the MSA broth.
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Table 1: Group allocation of the experimental rabbits in the trial.

Group Name
Group A
Group B
Group C
Group D
Group E

No. of Animals
4
4
4
4
4

Infected/ Not Infected
Infected
Infected
Infected
Infected
Not Infected

Treatment
Artemisinin @1mg/ml
Artemisinin @2mg/ml
Artemisinin @5mg/ml
Commercial antibiotic
Placebo (PBS)

Figure 6: Inoculation of bacteria in the rabbits via subcutaneous route and subsequently their treatment.

For this purpose, three dilutions
of 1 mg/ml, 2 mg/ml and 5 mg/ml were
prepared from the Artemisinin extracts.
And 05 test tubes A, B, C, D, and E were
prepared having broth in these tubes and
bacterial inoculums from the cultures were
introduced into the 04 test tubes, A, B, C
and D, while, the 5th test tube E served as
negative control. Subsequently, the
Artemisinin dilutions were added as 1
mg/ml, 2 mg/ml and 5 mg/ml in test tubes

A, B and C, respectively, while, D served
as positive control having inoculums only
and E served as negative control (without
inoculums and Artemisinin extracts). After
overnight incubation at 37 0C, test tubes
were examined for bacterial colonies and
growths and it was manifested that test
tube B was completely turbid, being
positive control, and Test tube C having 5
mg/ml of Artemisinin extracts was clear
followed by Test tube B and A (Figure 4).

Table 2: Details of samples cultured on different media used in the study.

Culture Media

Samples
Cultured

Mannitol Salt Agar

40

Growth
bacteria
media
28

of Name of Bacteria
in

MacConkey Agar

30

13

Staphylococcus
aureus
Escherichia coli

Nutrient Agar

30

21

Streptococcus

Total Samples

100

62

----
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Milk (40)
Intestinal contents of
poultry (8/15), fecal
material (5/15)
Milk samples (15/20),
Blood samples (6/10)
----

47

Khan et al., (2022). Evaluation of Antibacterial Potential of Artemisinin Extracts.
J Biores Manag., 9(4): 42-52

Figure 7: Growth of S. aureus bacteria on the Mannitol Salt Agar and microscopic view of the slide
prepared from this culture.

Figure 8: The culture sensitivity test on MHA
and comparison of the zone of inhibition of
different antibiotics.

The results revealed the significant
antibacterial potential of the Artemisinin
extracts @ 5 mg/ml, followed by 2 mg/ml
and 1 mg/ml. So, the minimum inhibitory
concentration of the Artemisinin extracts
was found to be 1 mg/ml.
In Vitro Study of Antibacterial Potential
of Artemisinin Extracts
To determine the antibacterial
potential
of
Artemisinin
extracts
(Artemisia annua) in vitro, three bacterial
species including S. aureus, E. coli and
Streptococcus (Table 2) and the
bacteriostatic zone of inhibition of
Artemisinin extracts were studied against
the test bacteria Staphylococcus aureus,
Streptococcus and Escherichia coli, on the
MHA media (Table 3) was also compared

with the antibacterial potential of the
commercially available antibiotics, by disk
diffusion method, by measuring the zone
of inhibition or bacteriostatic zone on the
MHA (Figure 8) (Table 4).
The diameter of the zone of
inhibition of the Artemisinin extracts was
highly sensitive to Staphylococcus aureus
(27.7 mm) followed by Streptococcus
(22.3 mm) and moderate sensitivity to
Escherichia coli (12.9 mm), as shown in
Table 4. Thus Artemisinin showed a
significant inhibitory effect against S.
aureus and Streptococcus. Similar studies
were conducted, which also confirmed the
significant role of Artemisinin extracts
against S. aureus. For instance, in a study,
the methanol and ethanol extracts of the
leaf extracts of Artemisinin were
compared with commercial antibiotic
ciprofloxacin. The results were also
comparable to our study, in which the
highest inhibition of the growth of S.
aureus was observed with the Artemisinin
extracts having a bacteriostatic zone of
16.5mm diameter (Tajehmiri et al., 2014).
In another study, the water extracts of
Artemisinin were compared with the
commercial antibiotic ciprofloxacin, by
disk diffusion method. The results
revealed the highest sensitivity of S.
aureus having a zone of inhibition of 21
mm, which was marked highly sensitive
and supported our results. But the zone of
inhibition against the E. coli was found at
15mm, which was also marked sensitive. It
was concluded by the scientists that
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Artemisinin extracts showed the highest
sensitivity to S. aureus and weaker
sensitivity to E. coli, as revealed in our
results (Tao et al., 2020). In another study,
the antimicrobial activity of Artemisinin
and its precursors was tested against five
bacterial species viz S. aureus, Bacillus
thuringiensis, B. subtilis, E. coli and
Salmonella. The study reported that
Artemisinin was highly effective against S.
aureus with TCs and had a significant
inhibition zone of 3 + 1.58 mm as that of
the commercial antibiotic Streptomycin
(Appalasamy et al., 2014). Rolta et al.

(2021) also reported that the Artemisia
annua L. herb can be strategically used as
bio-enhancers against S. aureus and E. coli
strains. Our study was also coinciding with
the study conducted by Mohammed et al.
(2022), whereby it was reported in the
results that the crude extracts of the
Artemisia herb showed significant
antimicrobial potential against the S.
aureus and E. coli pathogenic bacteria,
with the diameter of the bacteriostatic zone
as 20.33 and 15.67 mm, respectively.

Table 3: The bacteriostatic zones of inhibition of the Artemisinin extracts of Artemisia annua against
different bacterial strains

Bacterial species

Zone of Inhibition on MHA (mm)
1
2
3
4
5
6
25
27
23 29
28
27
21
22
23 21
25
24
11
12
10 8
13
15

7
8
9
Staphylococcus aureus
28
26
27
Streptococcus
20
19
28
Escherichia coli
11
12
10
Note: Chi-squared test for given probabilities, X-squared = 93.431, df = 34, p-value = 1.89e-07

10
28
22
15

11
27
22
12

Table 4: The comparison of bacteriostatic zones of Artemisinin extracts with the commercial antibiotics
on disc diffusion method against test microorganisms.

Bacterial species
Staphylococcus
aureus
Streptococcus
Escherichia coli

Zone of Inhibition on MHA (mm)
Artemisinin Amox
Enro
Doxy
27.7
25.1
21.1
17.3

Tetra
19.3

Cipro
30.4

Oxy
29.4

22.3
12.9

22.6
11.4

27.5
26.1

25.9
27.8

24.6
13.2

24.2
17.7

23.5
11.5

Note: Chi-squared test for given probabilities, X-squared = 60.655, df = 22, p-value = 1.787e-05.
Amox* Amoxicillin; Enro* Enroflaxacin; Doxy* Doxycycline; Tetra* Tetracycline; Cipro* Ciprofloxacin; Oxy*
Oxytetracycline.
Table 5: Sensitivity of Artemisinin extracts and commercial antibiotics against the test microbes

Bacterial
species
Staphylococcus
aureus
Streptococcus
Escherichia coli

Sensitivity against the test microbes
Artemisini
Amox
Enro
n
Sensitive
Sensitive
Sensitive
Sensitive
Moderate

Sensitive
Moderate

Sensitive
Moderate

Doxy

Tetra

Cipro

Oxy

Moderate

Moderate

Sensitive

Sensitive

Sensitive
Resistant

Sensitive
Resistant

Sensitive
Sensitive

Sensitive
Sensitive
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Zone of Inhibition of Test Herb
From the current study, it was
revealed
that
Artemisinin
showed
significant sensitivity to the test microbes
S. aureus and Streptococcus, while,
moderate sensitivity was observed against
Escherichia coli (Table 5).
In vivo study of antibacterial
potential of Artemisinin extracts of
Artemisia annua in rabbit models
For in vivo study, a total of 20
rabbits of the same age and breed were
allocated into 05 groups viz Group A, B,
C, D and E (Table 1) and were initially
infected with the S. aureus and then
Streptococcus bacterial infection through
intradermal inoculation route @ 300 CFU
diluted in 0.1ml phosphate buffer saline
and finally Escherichia coli were injected
intraperitoneally into the rabbits @ 1.0 ml
bacterial suspension of E. coli (@ 108
CFU/ml), with breach of 1-2 weeks posts
each infection Thereafter, the infected
rabbits
showed
typical
clinical
manifestations in terms of depression,

dullness, inactivity, inappetence, anorexia,
pyrexia, etc and the rabbits infected with
E. coli were also diarrheic (Guo et al.,
2017).
Then the rabbits were treated using
different concentrations of Artemisinin @
1 mg/ml, 2 mg/ml and 5 mg/ml,
respectively, via the intramuscular route,
Group D served as positive control and
was treated using commercial antibiotics
e.g. amoxicillin @ 5 mg/kg body weight
for 05 days, while, Group E served as
negative control and treated using a
placebo (1 ml Phosphate buffer saline
solution) through intramuscular route
(Table 1). After 3-5 days of each infection,
the following results were seen during this
in vivo phase (Table 6). The results of our
study revealed that all the rabbits infected
with S. aureus recovered by treatment with
the Artemisinin extract @ 1 mg/ml, 2
mg/ml and 5 mg/ml, but 03 out of 15
rabbits of Group A, B, C treated with
Artemisinin extracts @ 1 mg/ml, 2 mg/ml
and 5 mg/ml, had died.

Table 6: Treatment of rabbit models, via in vivo test against the test bacteria.

Treatment of rabbit models infected with Staphylococcus bacteria
Group Name
No. of Animals
Treatment
Group A
4
Artemisinin @1mg/ml
Group B
4
Artemisinin @2mg/ml
Group C
4
Artemisinin @5mg/ml
Group D
4
Amoxycillin @5mg/kg
body weight
Group E
4
Placebo (PBS)
Treatment of rabbit models infected with Streptococcus
Group A
4
Artemisinin @1mg/ml
Group B
4
Artemisinin @2mg/ml
Group C
4
Artemisinin @5mg/ml
Group D
4
Amoxycillin @5mg/kg
body weight
Group E
4
Placebo (PBS)
Treatment of rabbit models infected with Escherichia coli
Group A
4
Artemisinin @1mg/ml
Group B
4
Artemisinin @2mg/ml
Group C
4
Artemisinin @5mg/ml
Group D
4
Ciprofloxacin @20mg/kg
body weight
Group E
4
Placebo (PBS)
© 2022 by Journal of Bioresource Management is licensed under CC BY
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Therefore, as per the outcomes of
this study, the Artemisinin extracts are
highly effective against S. aureus and
Streptococcal infections but have little
effect on in vivo treatment of E. coli
infections. Our results are supported by the
study in which the Artemisinin extract was
recommended against S. aureus and
Streptococci bacteria (Tao et al., 2020).
Another study also supported our results in
which it was reported that the Artemisia
annua herb had potential bactericidal
peptide activities against the pathogenic
bacteria in the rabbit models (Ding et al.,
2019).
CONCLUSION
It has been concluded from the
study that the Artemisinin extracts of the
herb
Artemisia
annua,
possessed
significant antibacterial potential against
the Staphylococcus aureus as well as
Streptococcus bacteria, which was tested
both in vitro and in vivo, using disk
diffusion method and rabbit models,
respectively. While Artemisinin extract
had little effect against the Escherichia
coli bacteria in both in vitro and in vivo
trials. Therefore, as per findings of this
study, the Artemisinin extracts are highly
recommended for the treatment of
bacterial infections caused by S. aureus
and Streptococcus bacteria in animals and
humans, as a complementary and
alternative medicine (CAM), being a
natural
herb,
bearing
significant
therapeutic potential with less adverse
effects.
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